U S PHYSICAL THERAPY INC /NV(USPH)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #1,066 of 2,879 stocksTOP 50%
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
USPH Stock Analysis & AI Quality Score
AI stock analysis and institutional research for U S PHYSICAL THERAPY INC /NV (USPH), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores USPH at 57.2/100 on a 32-signal composite quality model, placing it at rank #1,066 of 2,879 stocks — the top half of the AI-ranked universe. Based on the latest XBRL financial filings (Q1 2026), U S PHYSICAL THERAPY INC /NV reports quarterly revenue of $198.3M, net income of $5.0M, an operating margin of 6.3%. Top institutional holders of USPH by reported 13-F value include BlackRock,, KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT, MORGAN STANLEY, based on the most recent SEC filings. USPH trades on the NYSE exchange and files with the SEC under CIK 885978. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate USPH daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for U S PHYSICAL THERAPY INC /NV directly from SEC EDGAR. U S PHYSICAL THERAPY INC /NV's 13F Pro composite quality score has ranged between 8 and 71 since 2021, currently 57.2 — an improving long-term trajectory across 56 quarterly and live scoring snapshots.
Revenue
Q1 2026
$198.3M
Net Income
Q1 2026
$5.0M
Free Cash Flow
Q1 2026
$-1.6M
Operating Margin
Q1 2026
6.3%
ROIC
Q1 2026
1.9%
D/E Ratio
Q1 2026
0.44
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · Pro+Revenue
+29.1% YoYNet Income
+40.2% YoYOperating Income
+71.6% YoYEPS (Diluted)
+10.9% YoYTotal Assets
+20.7% YoYTotal Debt
+10.8% YoYOp. Cash Flow
-8.4% YoY| Metric | FY 2025 | FY 2023 | FY 2021 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|
| Revenue | $781.0M +29.1% | $604.8M +22.2% | $495.0M +2.7% | $482.0M +16.4% | $414.1M +16.1% | $356.5M |
| Net Income | $39.6M +40.2% | $28.2M -30.8% | $40.8M +2.0% | $40.0M +79.9% | $22.3M +8.3% | $20.6M |
| Operating Income | $86.7M +71.6% | $50.5M -28.5% | $70.6M +4.8% | $67.4M +23.2% | $54.7M +10.5% | $49.5M |
| EPS (Diluted) | $1.42 +10.9% | $1.28 -46.9% | $2.41 -1.6% | $2.45 | — | — |
| Total Assets | $1.20B +20.7% | $997.2M +33.1% | $749.4M +33.6% | $560.8M +33.9% | $419.0M +19.3% | $351.2M |
| Total Debt | $162.5M +10.8% | $146.7M +23.9% | $118.4M +128.5% | $51.8M -20.1% | $64.8M +22.2% | $53.0M |
| Operating Cash Flow | $75.1M -8.4% | $82.0M +7.3% | $76.4M +22.4% | $62.4M +10.5% | $56.5M +10.7% | $51.0M |
AI Insight: USPH Financial Trends
Revenue growth stalls at $198M while debt surges to $205M and operating income collapses to $12M in Q1 2026 — the weakest margin in the observed period.
• Revenue grew steadily from $167M in Q2 2024 to $203M in Q4 2025, but stalled at $198M in Q1 2026.
• Operating income fell sharply from $25M in Q3 2025 to $12M in Q1 2026, the lowest level across all eight quarters.
• Net income dropped from $13M in Q3 2025 to $4M in Q4 2025 and only partially recovered to $5M in Q1 2026.
• Total debt jumped from $162M in Q4 2025 to $205M in Q1 2026, the largest single-quarter increase in the dataset.
⚠ Operating cash flow collapsed to $4M in Q1 2026 from $25M in Q4 2025 — debt-financed growth may be straining cash generation.
⚠ Equity declined to $469M in Q1 2026, the lowest in the period, as rising debt and weak earnings erode the balance sheet.
⚠ The $43M debt increase in Q1 2026 warrants monitoring — identify whether acquisitions or operational shortfalls are driving leverage higher.
AI Insight: USPH Ratio Trends
USPH's profitability collapsed in Q4 2025–Q1 2026 after peaking in Q3 2025, with ROIC halving from 15.3% to 7.4% and D/E jumping to 0.44.
• Operating margin surged from 5.6% in Q3 2024 to a peak of 12.8% in Q3 2025, then reversed sharply to 6.3% in Q1 2026.
• ROIC peaked at 15.3% in Q3 2025 but dropped to 7.4% in Q1 2026 — the lowest level in the entire data series.
• D/E ratio rose from 0.32 in Q3 2025 to 0.44 in Q1 2026, erasing prior leverage discipline and matching the TTM figure.
• Net profit margin fell from 6.7% in Q3 2025 to just 2.1% in Q4 2025 and 2.5% in Q1 2026, signaling meaningful earnings pressure.
⚠ D/E spiked to 0.44 in Q1 2026 — first time at this level in the dataset — monitor whether leverage continues rising or stabilizes.
⚠ Q3 2024 showed a similar mid-year margin trough (OpMargin 5.6%) before recovery; watch if Q1 2026 weakness is seasonal or structural.
⚠ ROA dropped to 1.6% in Q1 2026 from a peak of 4.4% in Q3 2025 — asset productivity deterioration warrants close monitoring.
Get alerted when USPH's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for U S PHYSICAL THERAPY INC /NV including:
Top Institutional Holders of USPH
BlackRock, Inc.
$165.5M2,208,511 shKAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC
$79.9M1,065,856 shMORGAN STANLEY
$75.1M1,002,468 shBAHL & GAYNOR INC
$63.4M845,388 shCopeland Capital Management, LLC
$62.7M836,831 shVANGUARD CAPITAL MANAGEMENT LLC
$49.8M664,062 shSTATE STREET CORP
$48.9M648,387 shBANK OF AMERICA CORP /DE/
$41.6M554,621 shDIMENSIONAL FUND ADVISORS LP
$38.0M507,394 shSOUTHERNSUN ASSET MANAGEMENT, LLC
$33.0M439,904 sh
| Fund | Value | Shares |
|---|---|---|
| BlackRock, Inc. | $165.5M | 2,208,511 |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | $79.9M | 1,065,856 |
| MORGAN STANLEY | $75.1M | 1,002,468 |
| BAHL & GAYNOR INC | $63.4M | 845,388 |
| Copeland Capital Management, LLC | $62.7M | 836,831 |
| VANGUARD CAPITAL MANAGEMENT LLC | $49.8M | 664,062 |
| STATE STREET CORP | $48.9M | 648,387 |
| BANK OF AMERICA CORP /DE/ | $41.6M | 554,621 |
| DIMENSIONAL FUND ADVISORS LP | $38.0M | 507,394 |
| SOUTHERNSUN ASSET MANAGEMENT, LLC | $33.0M | 439,904 |
More Healthcare Companies
View all Healthcare →Put USPH on your watchlist
Track score changes the day U S PHYSICAL THERAPY INC /NV files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is USPH a good stock to buy?
13F Pro's AI-powered analysis of U S PHYSICAL THERAPY INC /NV (USPH) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for USPH are available on the USPH stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own USPH?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling USPH. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of U S PHYSICAL THERAPY INC /NV's investment landscape.